TNF and rheumatoid arthritis: Progressively decreasing response rates to biologic agents have been observed according to whether the study population comprises patients with early RA or established RA, is MTX-naïve or MTX-experienced, or includes patients with late anti-tumor necrosis factor (TNF)-experienced RA [15].